Fmoc-Asn(Trt)-Thr(Psi(Me,Me)pro)-OH

Fmoc-Asn(Trt)-Thr(Psi(Me,Me)pro)-OH is an Fmoc-protected asparagine-threonine dipeptide-like amino acid derivative in which the Asn side-chain amide is protected as a Trt (trityl) group and the Thr side chain is converted into a constrained Psi(Me,Me)pro residue bearing a proline-like, gem-dimethyl substituted side-chain architecture. The molecule contains an Fmoc carbamate on the amino terminus, a free carboxylic acid at the C-terminus for peptide coupling, and multiple aromatic protecting-group elements that modulate nucleophilicity and suppress side reactions during solid-phase or solution-phase assembly. The stereochemical integrity at the Thr center is embedded in the Psi(Me,Me)pro motif, which is designed to control backbone conformation and can influence amide bond geometry in downstream peptidomimetic structures. The presence of a protected amide side chain and a conformationally restricted threonine analog makes the compound suitable for building structure-defined peptide analogs and for generating synthesis intermediates that tolerate standard amino acid coupling and orthogonal deprotection strategies.

1. Peptide Synthesis

Fmoc-Asn(Trt)-Thr(Psi(Me,Me)pro)-OH supports peptide building-block workflows by combining an Fmoc-protected N-terminus with a terminal carboxylic acid for coupling to activated amino acids or resin-bound fragments. The Asn(Trt) side-chain protection reduces undesired acylation or cross-reactivity of the asparagine amide during chain elongation, while the Psi(Me,Me)pro threonine analog provides a stereodefined, conformationally constrained residue that can be incorporated into peptide sequences using standard peptide coupling chemistries. Orthogonal removal of the Trt group under acidic conditions, followed by Fmoc deprotection, enables sequential exposure of functional groups for subsequent coupling or side-chain modification. Resulting peptide products can be used as defined scaffolds for mapping backbone effects, stabilizing bioactive conformations, and preparing peptidomimetic libraries with controlled functional-group presentation.

2. Peptidomimetics And SAR Studies

Fmoc-Asn(Trt)-Thr(Psi(Me,Me)pro)-OH is suitable for peptidomimetic construction where conformational restriction and side-chain electronics are used to tune molecular recognition. The Psi(Me,Me)pro motif replaces a native threonine side-chain environment with a proline-like, gem-dimethyl constrained element that can bias local backbone torsions, while the Asn(Trt) residue preserves the capacity for hydrogen-bonding patterns after deprotection. The protected amide side chain allows incorporation without premature intramolecular interactions, supporting controlled generation of analogs for structure-activity relationship studies focused on backbone geometry and side-chain orientation. Downstream derivatives can be synthesized into analog panels for SAR-driven optimization of peptide-like ligands, including variants that probe the impact of constrained residues on binding-site complementarity.

3. Protected Amino Acid Chemistry

Fmoc-Asn(Trt)-Thr(Psi(Me,Me)pro)-OH functions as a protected amino acid derivative that integrates orthogonal protection logic across both amino and side-chain functionalities. The Fmoc group provides base-labile N-terminal protection for iterative coupling, whereas the Trt group on the asparagine side-chain amide is acid-labile, enabling selective deprotection when the synthetic sequence requires exposure of the side-chain for further transformations. The carboxylic acid at the C-terminus participates in standard activation chemistry to form amide bonds, while the constrained Psi(Me,Me)pro residue can reduce conformational averaging, improving reproducibility of subsequent functional-group chemistry. The compound can therefore serve as a reliable intermediate for generating protected peptide fragments, preparing sequence-defined building blocks, and supporting downstream derivatization steps such as side-chain functional conversion after controlled deprotection.

4. Chemical Biology And Protein Engineering

Fmoc-Asn(Trt)-Thr(Psi(Me,Me)pro)-OH can be employed in chemical biology and protein engineering contexts where peptide segments are used to probe or modulate biomolecular interfaces. The Asn side-chain amide, once liberated from Trt, can participate in hydrogen-bond networks that are relevant to receptor recognition, enzyme-substrate mimicry, or protein-protein interaction mapping. The stereochemically defined Psi(Me,Me)pro residue can be incorporated into peptide probes to examine how backbone constraint affects binding modes, stability against proteolysis, or tolerance to conformational strain in a target microenvironment. Resulting peptidomimetic constructs can be used as research reagents for designing sequence variants, building interaction-focused libraries, and generating structured ligands for mechanistic studies in applied biochemical research.

5. Pharmaceutical And Fine Chemical Manufacturing

Fmoc-Asn(Trt)-Thr(Psi(Me,Me)pro)-OH is relevant to pharmaceutical manufacturing and fine chemical synthesis as a chiral, protected amino acid intermediate that supports controlled assembly of peptide-like ingredients and processable intermediates. The combination of Fmoc protection and side-chain Trt protection aligns with scalable peptide synthesis strategies that require predictable deprotection windows and suppression of side reactions during chain growth. The terminal carboxylic acid enables conversion into activated derivatives for fragment coupling steps, supporting manufacturing route design for defined peptidomimetic sequences used in research-grade and industrial peptide workflows. The constrained Psi(Me,Me)pro architecture can also assist in producing analogs with consistent stereochemical outcomes, facilitating downstream purification and enabling reliable generation of peptide building blocks for specialty chemical production.

1. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate

2. The effect of sex on immune responses to a homocitrullinated peptide in the DR4-transgenic mouse model of Rheumatoid Arthritis

3. Identification, Localization in the Central Nervous System and Novel Myostimulatory Effect of Allatostatins in Tenebrio molitor Beetle

4. Crystal Structure of BamB from Pseudomonas aeruginosa and Functional Evaluation of Its Conserved Structural Features

5. Effect of Probiotic Lactobacillus plantarum on Streptococcus mutans and Candida albicans Clinical Isolates from Children with Early Childhood Caries